Iridology and Nutrition, Iridology Analysis As an Indicator of a Successful Healing Process

The holistic model of medicine cannot be imagined without iridology and nutrition. In fact, iridology and nutrition are heavily interrelated and complement each other.When iridology analysis reveals inherent weakness in the digestive system or toxicity in elimination organs, it precisely means that the body’s nutrition is suffering. On the other hand, iridology analysis when provided after the prescribed nutrition program allows to assess the success of this program and to understand what else this patient needs to do to bring his mind and body back to balance.Detoxification is a key process linking iridology and nutrition together. Successful detoxification program dramatically improves nutrition and iridology analysis could be a measure of this success. It also could be the other way around. Iridology analysis can help to understand what kind of nutritional requirements the body needs and based on this knowledge, a doctor can develop a proper nutritional program to correct the nutritional deficiencies of the patient.There are three important zones in irises that we need to analyze to assess the nutrition level of the body. The first one is the humoral or assimilation zone. This zone situated just outside the digestive reflexes and gives valuable information about the normalcy or pathology of the digestive process, specifically about how food is transported and distributed. Any congestive signs in this zone could affect digestion and absorption, in turn affecting nutrition.The second important iris zone in nutrition assessment is the utilization zone. This zone shows the distribution and use of the nutrients inside of the body. Here all nutrients are put to use for all major organs. Any signs of blockage and congestion point out the disruptions of this gentle process and ultimately suggest poor nutrition.And the third iris zone we need to analyze for nutritional assessment is, of course, the elimination zone, which includes the skin and the lymphatic system. The analysis of this zone shows how effectively and quickly the body system can eliminate toxins, residues, and metabolic waste. Any signs of weakness in this area also point to trouble with the body’s nutrition.An essential part of body nutrition is mental nutrition. Lack of stress, good sleep, and a good work-life balance promote good mental nutrition. Iridology analysis can assess mental nutrition by signs of stress (like stress rings, impediments of nerve wreath, etc.) and show signs of weakness in the brain area. And this knowledge could help to prescribe proper nutrition program for a specific patient.To summarize, just as nutrition proves the value of iridology, iridology proves the value of nutrition.

S&P 500 Biotech Giant Vertex Leads 5 Stocks Showing Strength

Your stocks to watch for the week ahead are Cheniere Energy (LNG), S&P 500 biotech giant Vertex Pharmaceuticals (VRTX), Cardinal Health (CAH), Steel Dynamics (STLD) and Genuine Parts (GPC).

X
While the market remains in correction, with analysts and investors wary of an economic downturn, these five stocks are worth adding to watchlists. S&P 500 medical giants Vertex and Cardinal Health have been holding up, as health-care related plays tend to do well in down markets.

Steel Dynamics and Genuine Parts are both coming off strong earnings as both the steel and auto parts industries report optimistic outlooks. Meanwhile, Cheniere Energy saw sales boom in the second quarter as demand in Europe for natural gas continues to grow.

Major indexes have been making rally attempts with the Dow Jones and S&P 500 testing weekly support on Friday. With market uncertainty, investors should be ready for follow-through day breakouts and keep an eye on these stocks.

Cheniere Energy, Cardinal Health and VRTX stock are all on IBD Leaderboard.

Cheniere Energy Stock
LNG shares rose 1.1% to 175.79 during Friday’s market trading. On the week, the stock advanced 3.1%, not from highs, bouncing from its 21-day and 10-week lines earlier in the week.

Cheniere Energy has been consolidating since mid-September, but needs another week to forge a proper base, with a potential 182.72 buy point formed on Aug. 10.

Houston-based Cheniere Energy was IBD Stock Of The Day on Thursday, as the largest U.S. producer of liquefied natural gas eyes strong demand in Europe.

Even though natural gas prices are plunging in the U.S. and Europe, investors still see strong LNG demand for Cheniere and others.

The U.K. government confirmed last week that it is in talks for an LNG purchase agreement with a number of companies, including Cheniere.

In the first half of 2021, less than 40% of Cheniere’s cargoes of LNG landed in Europe. That jumped to more than 70% through this year’s second quarter, even as the company ramped up new export capacity. The urgency of Europe’s natural gas shortage only intensified last month. That is when an explosion disabled the Nord Stream 1 pipeline from Russia that had once supplied 40% of the European Union’s natural gas.

In Q2, sales increased 165% to $8 billion and LNG earned $2.90 per share, up from a net loss of $1.30 per share in Q2 2021. The company will report Q3 earnings Nov. 3, with investors seeing booming profits for the next few quarters.

Cheniere Energy has a Composite Rating of 84. It has a 98 Relative Strength Rating, an exclusive IBD Stock Checkup gauge for share price movement with a 1 to 99 score. The rating shows how a stock’s performance over the last 52 weeks holds up against all the other stocks in IBD’s database. The EPS rating is 41.

Vertex Stock
VRTX stock jumped 3.4% to 300 on Friday, rebounding from a test of its 50-day moving average. Shares climbed 2.2% for the week. Vertex stock has formed a tight flat base with an official buy point of 306.05, according to MarketSmith analysis.

The stock has remained consistent over recent weeks, while the relative strength line has trended higher. The RS line tracks a stock’s performance vs. the S&P 500 index.

Vertex Q3 earnings are on due Oct. 27. Analysts see EPS edging up 1% to $3.61 per share with sales increasing 16% to $2.2 billion, according to FactSet.

The Boston-based global biotech company dominates the cystic fibrosis treatment market. Vertex also has other products in late-stage clinical development that target sickle cell disease, Type 1 diabetes and certain genetically caused kidney diseases. That includes a gene-editing partnership with Crispr Therapeutics (CRSP).

In early August, Vertex reported better-than-expected second-quarter results and raised full-year sales targets.

S&P 500 stock Vertex ranks second in the Medical-Biomed/Biotech industry group. VRTX has a 99 Composite Rating. Its Relative Strength Rating is 94 and its EPS Rating is 99.

CRISPR Stocks: Will Concerns Over Risk Inhibit Gene-Editing Cures?

Cardinal Health Stock
CAH stock advanced 3.2% to 73.03 Friday, clearing a 71.22 buy point from a shallow cup-with-handle base and hitting a record high. But volume was light on the breakout. CAH stock leapt 7.3% for the week.

Cardinal Health stock’s relative strength line has also been trending up for months.

The cup-with-handle base is part of a base-on-base pattern, forming just above a cup base cleared on Aug. 11.

Cardinal Health, based in Dublin, Ohio, offers a wide assortment of health care services and medical supplies to hospitals, labs, pharmacies and long-term care facilities. The company reports that it serves around 90% of hospitals and 60,000 pharmacies in the U.S.

S&P 500 stock Cardinal Health will report Q1 2023 earnings on Nov. 4. Analysts forecast earnings falling 26% to 96 cents per share. Sales are expected to increase 10% to $48.3 billion, according to FactSet.

Cardinal Health stock ranks first in the Medical-Wholesale Drug/Supplies industry group, ahead of McKesson (MCK), which is also showing positive action. CAH stock has a 94 Composite Rating out of 99. It has a 97 Relative Strength Rating and an EPS rating of 73.

Steel Dynamics Stock
STLD shares shot up 8.5% to 92.92 on Friday and soared 19% on the week, coming off a Steel Dynamics earnings beat Wednesday night.

Shares blasted above an 88.72 consolidation buy point Friday after clearing a trendline Thursday. STLD stock is 17% above its 50-day line, definitely extended from that key average.

Steel Dynamics’ latest consolidation could be seen as part of a larger base going back six months.

Steel Dynamics topped Q3 earnings views with EPS rising 10% to $5.46 while revenue grew 11% to $5.65 billion. The steel producer’s outlook is optimistic despite weaker flat rolled steel pricing. STLD reports its order activity and backlogs remain solid.

The Fort Wayne, Indiana-based company is among the largest producers of carbon steel products in the U.S. It engages in metal recycling operations along with steel fabrication and produces myriad steel products.

How Millett Grew Steel Dynamics From A Three Employee Business

STLD stock ranks first in the Steel-Producers industry group. STLD stock has a 96 Composite Rating out of 99. It has a 90 Relative Strength Rating, an exclusive IBD Stock Checkup gauge for share-price movement that tops at 99. The rating shows how a stock’s performance over the last 52 weeks holds up against all the other stocks in IBD’s database. The EPS rating is 98.

Genuine Parts Stock
GPC stock gained 2.8% to 162.35 Friday after the company topped earnings views with its Q3 results on Thursday. For the week GPC advanced 5.1% as the stock held its 50-day line and is in a flat base.

GPC has an official 165.09 flat-base buy point after a three-week rally, according to MarketSmith analysis.

The relative strength line for Genuine Parts stock has rallied sharply to highs over the past several months.

On Thursday, the Atlanta-based auto parts company raised its full-year guidance on growth across its automotive and industrial sales.

Genuine Parts earnings per share advanced 19% to $2.23 and revenue grew 18% to $5.675 billion in Q3. GPC’s full-year guidance is now calling for EPS of $8.05-$8.15, up from $7.80-$7.95. The company now forecasts revenue growth of 15%-16%, up from the earlier 12%-14%.

During the Covid pandemic, supply chain constraints caused a major upheaval in the auto industry, sending prices for new and used cars to record levels. This has made consumers more likely to hang on to their existing vehicles for longer, driving mileage higher and boosting demand for auto replacement parts.

Fellow auto stocks O’Reilly Auto Parts (ORLY) and AutoZone (AZO) have also rallied near buy points amid the struggling market. O’Reilly reports on Oct. 26.

IBD ranks Genuine Parts first in the Retail/Wholesale-Auto Parts industry group. GPC stock has a 96 Composite Rating. Its Relative Strength Rating is 94 and it has an EPS Rating of 89.

What Are the Key Contributors of the Growing Demand For Pharmacy Technicians?

There are quite a number of positive developments which affect the increase of pharmacist Technicians in the past decades, some of them are:1. The gain of national certification on pharmacy Technician career and job has opened up a lot of opportunities for those who have the interest to become assistant to a pharmacist.2. The development of model curriculums for Pharmacy Technician training and a higher and greater level of recognition of pharmacy technicians in the State and Nation wide on pharmacy practice Acts have encouraged many potentials to seek for new employment opportunities as well as to seek for pharmacy technician’s courses in colleges or online.3. The roles and responsibilities of Pharmacy technicians have been more clearly defined in hospital, community centre, clinics and wherever the skill sets of pharmacy technicians are needed.
4. Increasingly, hospital pharmacies are encouraged to develop pharmacy technician programs and the increase changes being called out to ensure the roles of these technicians was appropriately articulated in state laws and regulations.5. The responsibilities of this professions have increased over the years from initially they are responsible for most of the clerical work only in the pharmacy ( similar to a clerk) … until they start to play the governance role for the state pharmacy association as well as the state board of pharmacy.6. The enablement of pharmacy asistants across multiple settings today, including community pharmacy, hospitals and health systems, long term care facilities, clinic pharmacies, health insurance companies, pharmaceutical whole-salers etc signify that this is a profession which is largely needed in a good wide spread of industry.7. In the recent years, pharmacists have become more receptive to pharmacy technicians compared to 15 years back where the latter is given the task of dispensing medicine only. However much has changed over the last few years in the potential increased in job scopes of pharmacy technicians.8. The enhancement in medical field has enabled new medications, antidotes to be invented across the world by the medical experts. This has significantly reduced non fatal deaths, reduce or eliminate significant pain of patients with this invention. With the prolonged age of the population in the society today, the demand for pharmacy technicians have significantly being increased as well.9. On the other hand, with the increase invention of of new medications invested and become available today, the pharmacists are faced with a greater number of prescriptions to dispense. This has directly reduced the bandwidth of the pharmacists, leaving them with lesser time for counseling patients. At the same time, their working conditions and schedules have deteriorated with an increase in job stress. This is where the importance of the pharmacy technicians comes into picture and they presence has helped to take over the tasks of dispensing the prescriptions to the patients.Pharmacy assistants as such has gained it popularity increasing nowadays and it is by no mistake on the increased demand of pharmacy technicians in many health sectors in the society today.